{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:18:34Z","timestamp":1762521514334,"version":"3.40.4"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,8,14]],"date-time":"2012-08-14T00:00:00Z","timestamp":1344902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2012,8,14]],"date-time":"2012-08-14T00:00:00Z","timestamp":1344902400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1007\/s12072-012-9396-x","type":"journal-article","created":{"date-parts":[[2012,8,13]],"date-time":"2012-08-13T14:21:13Z","timestamp":1344867673000},"page":"72-79","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["The new epidemiology of nosocomial bacterial infections in cirrhosis: therapeutical implications"],"prefix":"10.1007","volume":"7","author":[{"given":"Juan","family":"Acevedo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"An\u00edbal","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ver\u00f3nica","family":"Prado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,8,14]]},"reference":[{"issue":"Suppl 1","key":"9396_CR1","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/S0168-8278(12)60002-6","volume":"56","author":"J Fern\u00e1ndez","year":"2012","unstructured":"Fern\u00e1ndez J, Gustot T. Management of bacterial infections in cirrhosis. J Hepatol. 2012;56(Suppl 1):S1\u201312.","journal-title":"J Hepatol"},{"key":"9396_CR2","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1002\/hep.23264","volume":"50","author":"T Gustot","year":"2009","unstructured":"Gustot T, Durand F, Lebrec D, et al. Severe sepsis in cirrhosis. Hepatology. 2009;50:2022\u201333.","journal-title":"Hepatology"},{"key":"9396_CR3","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1055\/s-2008-1040319","volume":"28","author":"P Tandon","year":"2008","unstructured":"Tandon P, Garcia-Tsao G. Bacterial infections, sepsis, and multiorgan failure in cirrhosis. Semin Liver Dis. 2008;28:26\u201342.","journal-title":"Semin Liver Dis"},{"key":"9396_CR4","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1053\/jhep.2002.30082","volume":"35","author":"J Fern\u00e1ndez","year":"2002","unstructured":"Fern\u00e1ndez J, Navasa M, Gomez J, et al. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology. 2002;35:140\u20138.","journal-title":"Hepatology"},{"issue":"5","key":"9396_CR5","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1002\/hep.25532","volume":"55","author":"J Fern\u00e1ndez","year":"2012","unstructured":"Fern\u00e1ndez J, Acevedo J, Castro M, et al. Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study. Hepatology. 2012;55(5):1551\u201361.","journal-title":"Hepatology"},{"key":"9396_CR6","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1053\/j.gastro.2010.06.019","volume":"139","author":"V Arvaniti","year":"2010","unstructured":"Arvaniti V, D\u2019Amcio G, Fede G, et al. Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis. Gastroenterology. 2010;139:1246\u201356.","journal-title":"Gastroenterology"},{"key":"9396_CR7","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1378\/chest.124.3.1016","volume":"124","author":"MG Foreman","year":"2003","unstructured":"Foreman MG, Mannino DM, Moss M. Cirrhosis as a risk factor for sepsis and death: analysis of the National Hospital Discharge Survey. Chest. 2003;124:1016\u201320.","journal-title":"Chest"},{"key":"9396_CR8","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/j.1478-3231.2003.00870.x","volume":"23","author":"A Plessier","year":"2003","unstructured":"Plessier A, Denninger MH, Consigny Y, et al. Coagulation disorders in patients with cirrhosis and severe sepsis. Liver Int. 2003;23:440\u20138.","journal-title":"Liver Int"},{"key":"9396_CR9","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1002\/hep.510290608","volume":"29","author":"B Bernard","year":"1999","unstructured":"Bernard B, Grang\u00e9 JD, Khac EN, et al. Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis. Hepatology. 1999;29:1655\u201361.","journal-title":"Hepatology"},{"key":"9396_CR10","first-page":"2067","volume":"88","author":"H Yoshida","year":"1993","unstructured":"Yoshida H, Hamada T, Inuzuka S, et al. Bacterial infection in cirrhosis, with and without hepatocellular carcinoma. Am J Gastroenterol. 1993;88:2067\u201371.","journal-title":"Am J Gastroenterol"},{"key":"9396_CR11","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1002\/hep.1840160318","volume":"16","author":"J Llach","year":"1992","unstructured":"Llach J, Rimola A, Navasa M, et al. Incidence and predictive factors of first episode of spontaneous bacterial peritonitis in cirrhosis with ascites: relevance of ascitic fluid protein concentration. Hepatology. 1992;16:724\u20137.","journal-title":"Hepatology"},{"key":"9396_CR12","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1002\/hep.1840120416","volume":"12","author":"P Gin\u00e8s","year":"1990","unstructured":"Gin\u00e8s P, Rimola A, Planas R, et al. Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial. Hepatology. 1990;12:716\u201324.","journal-title":"Hepatology"},{"key":"9396_CR13","doi-asserted-by":"publisher","first-page":"666","DOI":"10.3346\/jkms.2006.21.4.666","volume":"21","author":"JY Song","year":"2006","unstructured":"Song JY, Jung SJ, Park CW, et al. Prognostic significance of infection acquisition sites in spontaneous bacterial peritonitis: nosocomial versus community acquired. J Korean Med Sci. 2006;21:666\u201371.","journal-title":"J Korean Med Sci"},{"key":"9396_CR14","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1086\/597585","volume":"48","author":"HS Cheong","year":"2009","unstructured":"Cheong HS, Kang C, Lee JA, et al. Clinical significance and outcome of nosocomial acquisition of spontaneous bacterial peritonitis in patients with liver cirrhosis. Clin Infect Dis. 2009;48:1230\u20136.","journal-title":"Clin Infect Dis"},{"key":"9396_CR15","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.jhep.2011.11.010","volume":"56","author":"X Ariza","year":"2012","unstructured":"Ariza X, Castellote J, Lora-Tamayo J, et al. Risk factors for resistance to ceftriaxone and its impact on mortality in community, healthcare and nosocomial spontaneous bacterial peritonitis. J Hepatol. 2012;56:825\u201332.","journal-title":"J Hepatol"},{"key":"9396_CR16","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1086\/520273","volume":"26","author":"B Campillo","year":"1998","unstructured":"Campillo B, Dupeyron C, Richardet JP, et al. Epidemiology of severe hospital-acquired infections in patients with liver cirrhosis: effect of long-term administration of norfloxacin. Clin Infect Dis. 1998;26:1066\u201370.","journal-title":"Clin Infect Dis"},{"key":"9396_CR17","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.cgh.2010.06.024","volume":"8","author":"M Merli","year":"2010","unstructured":"Merli M, Lucidi C, Giannelli V, et al. Cirrhotic patients are at risk for health care-associated bacterial infections. Clin Gastroenterol Hepatol. 2010;8:979\u201385.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"9396_CR18","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jhep.2004.10.019","volume":"42","author":"HE Wasmuth","year":"2005","unstructured":"Wasmuth HE, Kunz D, Yagmur E, et al. Patients with acute on chronic liver display \u201csepsis-like\u201d immune paralysis. J Hepatol. 2005;42:195\u2013201.","journal-title":"J Hepatol"},{"key":"9396_CR19","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1002\/hep.21737","volume":"46","author":"RP Mookerjee","year":"2007","unstructured":"Mookerjee RP, Stadlbauer V, Lidder S, et al. Neutrophil dysfunction in alcoholic hepatitis superimposed on cirrhosis is reversible and predicts the outcome. Hepatology. 2007;46:831\u201340.","journal-title":"Hepatology"},{"key":"9396_CR20","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1002\/hep.20632","volume":"41","author":"R Wiest","year":"2005","unstructured":"Wiest R, Garcia-Tsao G. Bacterial translocation (BT) in cirrhosis. Hepatology. 2005;41:422\u201333.","journal-title":"Hepatology"},{"key":"9396_CR21","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1046\/j.1440-1746.2003.03086.x","volume":"18","author":"YH Park","year":"2003","unstructured":"Park YH, Lee HC, Song HG, et al. Recent increase in antibiotic-resistant microorganism in patients with spontaneous bacterial peritonitis adversely affects the clinical outcome in Korea. J Gastroenterol Hepatol. 2003;18:927\u201333.","journal-title":"J Gastroenterol Hepatol"},{"key":"9396_CR22","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1471-2334-9-41","volume":"9","author":"KH Song","year":"2009","unstructured":"Song KH, Jeon JH, Park WB, et al. Clinical outcomes of spontaneous bacterial peritonitis due to extended spectrum beta-lactamase-producing Escherichia coli and Klebsiella species: a retrospective matched case-control study. BMC Infect Dis. 2009;9:41\u20136.","journal-title":"BMC Infect Dis"},{"key":"9396_CR23","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3904\/kjim.2004.19.3.160","volume":"19","author":"CI Kang","year":"2004","unstructured":"Kang CI, Kim SH, Park WB, et al. Clinical outcomes of bacteremic spontaneous bacterial peritonitis due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Korean J Intern Med. 2004;19:160\u20134.","journal-title":"Korean J Intern Med"},{"key":"9396_CR24","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.jhin.2009.02.021","volume":"73","author":"ME Falagas","year":"2009","unstructured":"Falagas ME, Karageorgopoulos DE. Extended-spectrum \u03b2-lactamase-producing organism. J Hosp Infect. 2009;73:345\u201354.","journal-title":"J Hosp Infect"},{"key":"9396_CR25","doi-asserted-by":"publisher","first-page":"44S","DOI":"10.1592\/phco.2005.25.10part2.44S","volume":"25","author":"GE Stein","year":"2005","unstructured":"Stein GE. Antimicrobial resistance in the hospital setting: impact, trends, and infection control measures. Pharmacotherapy. 2005;25:44S\u201354S.","journal-title":"Pharmacotherapy"},{"key":"9396_CR26","doi-asserted-by":"crossref","first-page":"26","DOI":"10.7326\/0003-4819-140-1-200401060-00008","volume":"140","author":"DL Paterson","year":"2004","unstructured":"Paterson DL, Ko WC, Von Gottberg A, et al. International prospective study of Klebsiella pneumoniae bacteremia: implications of Extended-spectrum \u03b2-lactamase production in nosocomial infections. Ann Intern Med. 2004;140:26\u201332.","journal-title":"Ann Intern Med"},{"key":"9396_CR27","doi-asserted-by":"publisher","first-page":"R142","DOI":"10.1186\/cc7119","volume":"12","author":"PO Depuydt","year":"2008","unstructured":"Depuydt PO, Vandijck DM, Bekaert MA, et al. Determinants and impact of multidrug antibiotic resistance in pathogens causing ventilator-associated-pneumonia. Crit Care. 2008;12:R142.","journal-title":"Crit Care"},{"key":"9396_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/340617","volume":"35","author":"B Campillo","year":"2002","unstructured":"Campillo B, Richardet JP, Kheo T, et al. Nosocomial spontaneous bacterial peritonitis and bacteremia in cirrhotic patients: impact of isolate type on prognosis and characteristics of infection. Clin Infect Dis. 2002;35:1\u201310.","journal-title":"Clin Infect Dis"},{"key":"9396_CR29","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s10096-002-0840-z","volume":"22","author":"F Bert","year":"2003","unstructured":"Bert F, Andreu M, Durand F, et al. Nosocomial and community-acquired spontaneous bacterial peritonitis: comparative microbiology and therapeutic implications. Eur J Clin Microbiol Infect Dis. 2003;22:10\u20135.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"9396_CR30","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1097\/MEG.0b013e3282fc7390","volume":"20","author":"F Cereto","year":"2008","unstructured":"Cereto F, Herranz X, Moreno E, et al. Role of host and bacterial virulence factors in Escherichia coli spontaneous bacterial peritonitis. Eur J Gastroenterol Hepatol. 2008;20:924\u20139.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"9396_CR31","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.3748\/wjg.14.2757","volume":"14","author":"S Angeloni","year":"2008","unstructured":"Angeloni S, Leboffe C, Parente A, et al. Efficacy of current guidelines for the treatment of spontaneous bacterial peritonitis in the clinical practice. World J Gastroenterol. 2008;14:2757\u201362.","journal-title":"World J Gastroenterol"},{"key":"9396_CR32","doi-asserted-by":"publisher","first-page":"197","DOI":"10.5009\/gnl.2009.3.3.197","volume":"3","author":"J Heo","year":"2009","unstructured":"Heo J, Seo YS, Yim HJ, et al. Clinical features and prognosis of spontaneous bacterial peritonitis in Korean patients with liver cirrhosis: a multicenter retrospective study. Gut Liver. 2009;3:197\u2013204.","journal-title":"Gut Liver"},{"key":"9396_CR33","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1007\/s10620-009-0825-1","volume":"55","author":"T Yakar","year":"2009","unstructured":"Yakar T, G\u00fc\u00e7l\u00fc M, Serin E, et al. A recent evaluation of empirical cephalosporin treatment and antibiotic resistance of changing bacterial profiles in spontaneous bacterial peritonitis. Dig Dis Sci. 2009;55:1149\u201354.","journal-title":"Dig Dis Sci"},{"key":"9396_CR34","first-page":"2","volume":"37","author":"L Piroth","year":"2009","unstructured":"Piroth L, Pechinot A, Minello A, et al. Bacterial epidemiology and antimicrobial resistance in ascetic fluid: a 2-year retrospective study. Scand J Infect Dis. 2009;37:2\u20138.","journal-title":"Scand J Infect Dis"},{"key":"9396_CR35","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s15010-008-8060-9","volume":"37","author":"A Umgelter","year":"2009","unstructured":"Umgelter A, Reindl W, Miedaner M, et al. Failure of current antibiotic first-line regimens and mortality in hospitalized patients with spontaneous bacterial peritonitis. Infection. 2009;37:2\u20138.","journal-title":"Infection"},{"key":"9396_CR36","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S1473-3099(11)70056-1","volume":"11","author":"G Cornaglia","year":"2011","unstructured":"Cornaglia G, Giamarellou H, Rossolini GM. Metallo-\u03b2-lactamases: a last frontier for \u03b2-lactams? Lancet Infect Dis. 2011;11:381\u201393.","journal-title":"Lancet Infect Dis"},{"key":"9396_CR37","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/j.1469-0691.2012.03821.x","volume":"18","author":"R Cant\u00f3n","year":"2012","unstructured":"Cant\u00f3n R, Ak\u00f3va M, Carmeli Y, et al. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clin Microbiol Infect. 2012;18:413\u201331.","journal-title":"Clin Microbiol Infect"},{"key":"9396_CR38","doi-asserted-by":"crossref","unstructured":"Piano S, Romano A, Rosi S et al. (2012) Spontaneous bacterial peritonitis due to carbapenemase-producing Klebsiella pneumoniae: the last therapeutic challenge. Eur J Gastroenterol Hepatol (Epub ahead of print).","DOI":"10.1097\/MEG.0b013e328355d8a2"},{"key":"9396_CR39","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1086\/533475","volume":"46","author":"A Apisarnthanarak","year":"2008","unstructured":"Apisarnthanarak A, Bailey TC, Fraser VJ. Duration of stool colonization in patients infected with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Clin Infect Dis. 2008;46:1322\u20133.","journal-title":"Clin Infect Dis"},{"key":"9396_CR40","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1469-0691.2009.02941.x","volume":"16","author":"OK Azap","year":"2010","unstructured":"Azap OK, Arslan H, Serefhano\u011flu K, et al. Risk factors for extended-spectrum \u03b2-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections. Clin Microbiol Infect. 2010;16:147\u201351.","journal-title":"Clin Microbiol Infect"},{"key":"9396_CR41","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1086\/604713","volume":"49","author":"R Ben-Ami","year":"2009","unstructured":"Ben-Ami R, Rodr\u00edguez-Ba\u00f1o J, Arslan H, et al. A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients. Clin Infect Dis. 2009;49:682\u201390.","journal-title":"Clin Infect Dis"},{"key":"9396_CR42","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1086\/649537","volume":"50","author":"J Rodr\u00edguez-Ba\u00f1o","year":"2010","unstructured":"Rodr\u00edguez-Ba\u00f1o J, Pic\u00f3n E, Gij\u00f3n P, et al. Community-onset bacteremia due to extended-spectrum \u03b2-lactamase-producing Escherichia coli: risk factors and prognosis. Clin Infect Dis. 2010;50:40\u20138.","journal-title":"Clin Infect Dis"},{"key":"9396_CR43","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1128\/JCM.02353-09","volume":"48","author":"J Rodr\u00edguez-Ba\u00f1o","year":"2010","unstructured":"Rodr\u00edguez-Ba\u00f1o J, Pic\u00f3n E, Gij\u00f3n P, et al. Risk factors and prognosis of nosocomial bloodstream infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli. J Clin Microbiol. 2010;48:1726\u201331.","journal-title":"J Clin Microbiol"},{"key":"9396_CR44","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/hep.1840050319","volume":"5","author":"J Felisart","year":"1985","unstructured":"Felisart J, Rimola A, Arroyo V, et al. Cefotaxime is more effective than is ampicillin-tobramycin in cirrhotics with severe infections. Hepatology. 1985;5:457\u201362.","journal-title":"Hepatology"},{"key":"9396_CR45","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1002\/hep.1840210312","volume":"21","author":"A Rimola","year":"1995","unstructured":"Rimola A, Salmer\u00f3n JM, Clemente G, et al. Two different dosages of cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis: results of a prospective, randomized, multicenter study. Hepatology. 1995;21:674\u20139.","journal-title":"Hepatology"},{"key":"9396_CR46","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/S0168-8278(00)80201-9","volume":"32","author":"A Rimola","year":"2000","unstructured":"Rimola A, Garc\u00eda-Tsao G, Navasa M, et al. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club. J Hepatol. 2000;32:142\u201353.","journal-title":"J Hepatol"},{"key":"9396_CR47","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.jhep.2010.05.004","volume":"53","author":"European Association for the Study of the Liver","year":"2010","unstructured":"European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol. 2010;53:397\u2013417.","journal-title":"J Hepatol"},{"key":"9396_CR48","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1002\/hep.22853","volume":"49","author":"BA Runyon","year":"2009","unstructured":"Runyon BA, AASLD Practice Guidelines Committee. Management of adult patients with ascites due to cirrhosis: an update. Hepatology. 2009;49:2087\u2013107.","journal-title":"Hepatology"},{"key":"9396_CR49","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1002\/hep.510290406","volume":"29","author":"J Ortiz","year":"1999","unstructured":"Ortiz J, Vila MC, Soriano G, et al. Infections caused by Escherichia coli resistant to norfloxacin in hospitalized cirrhotic patients. Hepatology. 1999;29:1064\u20139.","journal-title":"Hepatology"},{"key":"9396_CR50","volume-title":"Mandell, Douglas, and Bennett\u2019s Principles and Practice of Infectious Diseases","year":"2012","unstructured":"Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas, and Bennett\u2019s Principles and Practice of Infectious Diseases. 7th ed. London: Churchill Livingston Elsevier; 2012.","edition":"7"},{"key":"9396_CR51","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/j.1469-0691.2007.01835.x","volume":"14","author":"S Blot","year":"2008","unstructured":"Blot S. Limiting the attributable mortality of nosocomial infection and multidrug resistance in intensive care units. Clin Microbiol Infect. 2008;14:5\u201313.","journal-title":"Clin Microbiol Infect"},{"key":"9396_CR52","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/S1473-3099(11)70177-3","volume":"11","author":"E Tasina","year":"2011","unstructured":"Tasina E, Haidich AB, Kokkali S, et al. Efficacy and safety of tigecycline for the treatment of infectious diseases: a meta-analysis. Lancet Infect Dis. 2011;11:834\u201344.","journal-title":"Lancet Infect Dis"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-012-9396-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-012-9396-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-012-9396-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-012-9396-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T03:18:27Z","timestamp":1744168707000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-012-9396-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,14]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["9396"],"URL":"https:\/\/doi.org\/10.1007\/s12072-012-9396-x","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"type":"print","value":"1936-0533"},{"type":"electronic","value":"1936-0541"}],"subject":[],"published":{"date-parts":[[2012,8,14]]},"assertion":[{"value":"11 May 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}